Excel Industries will commission a new manufacturing facility with a capacity of 1265 MTPA for a specialty chemical at its Lote site by February 2027. The company disclosed the capacity addition on July 23, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This strategic move aims to diversify the firm's product portfolio, targeting both domestic and international markets without relying on external debt.

The disclosure was made pursuant to SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD/PoD2/I/3762/2026 dated January 30, 2026. Surendra Singhvi, Company Secretary, signed the letter submitted to the Listing Departments of BSE Ltd. and National Stock Exchange of India Ltd. The filing details the rationale, investment requirements, and timeline for the proposed capacity addition.

Project Details

The company stated that the existing capacity for this specific product is nil, making this a greenfield addition to its current operations. The investment of ₹5.05 crores will be fully funded through internal accruals, indicating no immediate impact on the company's leverage ratios or need for external capital raising.

Strategic Rationale

Management cited portfolio diversification as the primary driver for this expansion. By introducing a new specialty chemical, Excel Industries seeks to broaden its revenue streams beyond existing offerings. The product is expected to launch in February 2027, immediately following the commissioning of the production capacity.

What the Numbers Show

The decision to fund the ₹5.05 crore project entirely through internal accruals highlights strong cash flow generation capabilities within the organization. This self-funded approach minimizes financial risk while allowing the company to capture market share in the specialty chemicals segment. With target markets spanning both domestic and overseas geographies, the new capacity positions the company to address demand fluctuations in either region, potentially stabilizing revenue contributions from the chemicals division.

Excel Industries has completed its dedicated manufacturing setup for specialty chemicals on July 23, 2026, enabling it to commence supplies under a five-year binding term sheet signed with an Indian specialty chemicals company. The project, which incurred an estimated capital expenditure of ~₹40 crore, is projected to generate an annual income of ₹35-40 crore, net of raw material costs. This operational milestone strengthens the company’s position in the contract manufacturing space and diversifies its revenue base through long-term contractual visibility.

The completion aligns with the timelines agreed upon with the customer following the initial disclosure of the agreement in November 2025. In addition to the recurring annual income, the company is set to receive a trade advance of ₹25 crore from the customer, improving near-term cash flows. The facility was commissioned specifically to fulfill obligations under this long-term supply agreement, marking a strategic expansion into specialized contract manufacturing.

Project Financials and Terms

The following table outlines the key financial parameters of the completed project:

Management Commentary

Ravi Ashwin Shroff, Managing Director of Excel Industries, highlighted the significance of the timely completion. “We are pleased to announce the successful completion of the project for production for supplies against the long term supply agreement on July 23, 2026,” Shroff said. He noted that the achievement underscores the company’s execution abilities and commitment to meeting customer expectations. Shroff added that this development will set the base for more opportunities in the contract manufacturing space, reinforcing Excel Industries as a reliable partner.

Regulatory Disclosure

The update was submitted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Surendra Singhvi, Company Secretary of Excel Industries Limited, digitally signed the disclosure on July 23, 2026. The submission was addressed to the Listing Departments of both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE). The initial disclosure regarding the signing of the binding term sheet was made on November 13, 2025.

What the Numbers Show

The financial structure of this deal indicates strong unit economics for Excel Industries. With a capital outlay of ~₹40 crore generating ₹35-40 crore in net annual income, the project suggests a payback period of approximately one year from operations alone. The inclusion of a ₹25 crore trade advance further de-risks the investment by providing immediate liquidity before production revenues begin. This combination of high-margin contract manufacturing and upfront cash consideration signals a strategic shift towards more predictable, asset-light revenue streams within the specialty chemicals segment.